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Abstract. Nowadays there are new magnetic nanostructures based on bioactive metals with low toxicity and high 
efficiency for a wide range of biomedical applications including drugs delivery, antimicrobial drugs design, cells’ 
separation and contrasting. For such applications it is necessary to develop highly magnetic particles with less than 
100 nm in size. In the present study magnetic nanoparticles Fe, Fe3O4 and bimetallic Cu/Fe with the average size of 60–
90 nm have been synthesized by electrical explosion of wire in an oxygen or argon atmosphere. The produced 
nanoparticles have been characterized with transmission electron microscopy, X-ray phase analysis, and nitrogen thermal 
desorption. The synthesized particles have shown antibacterial activity to gram-positive (S. aureus, MRSA) and gram-
negative (E. coli, P. aeruginosa) bacteria. According to the cytological data Fe, Fe3O4and Cu/Fe nanoparticles have 
effectively inhibited viability of cancer cell lines Neuro-2a and J774. The obtained nanoparticles are promising for new 
antimicrobial drugs and antitumor agents’ development.
INTRODUCTION
Nowadays there has been a rising interest to the nanoparticles based on iron and its compounds for biomedical 
applications. Iron is a bioactive metal with magnetic properties and low toxicity to mammalian cells. Despite 
numerous reports devoted to iron compounds their antimicrobial and anticancer activity data is ambiguous. Using 
iron nanoparticles as antimicrobial agents against E. coli was shown in 2008 by Lee et al. [1]. At the same time, it 
was noted that iron nanoparticles’ activity is higher in anaerobic conditions. After saturation of nanoparticles’ 
suspension their oxidation in the air oxygen takes place. The oxide film formed on the surface of nanoparticles 
inhibits ion migration to suspension and results in low antimicrobial activity. The antimicrobial activity of iron 
nanoparticles was also shown in [2, 3] etc. The mechanism of iron nanoparticles action on microbial cell is based on 
physical disturbance of cell membrane and on reactive oxygen species (ROS) generation that are formed after 
interaction of iron ions with oxygen or hydrogenium peroxide. However, it was shown that only fresh produced iron 
nanoparticles had bactericidal effect. The influence of aging processes on antimicrobial activity of nanoparticles was 
shown in [4]. It was shown that iron oxide nanoparticles have a little antimicrobial activity against Bacillus subtilis
and Escherichia coli [5].Only the coating with chitosan molecule resulted in a significant increase in antimicrobial 
activity of iron oxide nanoparticles. Using nanoparticles containing iron as the anti-cancer agent [6] and potential 
drug carrier in cancer therapy has attracted much attention recently [7]. Such particles can also kill cancer cells 
because of generating ROS [8].
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Iron containing nanoparticles can be synthesized by various methods, mainly by colloidal chemistry methods and 
chemical precipitation. However, these processes include several toxic chemicals as reducing agents. In this regard 
development of pure synthesizing processes with electric explosion of the wire (EEW) is needed.
In the present work, we concentrated on producing Fe, Fe3O4 and bimetallic Cu/Fe nanoparticles by EEW 
method and on the comparison of nanoparticles’ antimicrobial activity and their anticancer effect.
MATERIALS ANDMETHODS
Fe and Fe3O4 nanoparticles were produced by the method of electric explosion (EEW) of iron wire in an argon 
and oxygen atmosphere respectively. Fe/Cu bimetallic nanoparticles were produced by EEW of simultaneous 
electric explosion of iron and copper twisted wires in an argon atmosphere [9]. The nanoparticle samples were 
passivated in air to decrease their pyrophorcity. The mass ratio of iron (wFe) and copper (wCu) in the nanopowder 
was 50 : 50 wt %.
The morphology of the nanoparticles and nanostructures was characterized by transmission electron microscopy 
(JEOL-2100, JEM, Japan, operated at 200 kV). The phase composition of the samples was determined by X-ray 
phase analysis with CuKĮ-emission (XRD-6000, Shimadzu, Japan). The specific surface areas of the 
micro/nanostructures were determined by the nitrogen adsorption method using a Sorbtometer M (Catakon, Russia). 
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Bacterial strains used for investigations were obtained from the Russian National Collection of Industrial 
Microorganisms: Staphylococcus aureus (Gram-positive) ATCC 29213 strain; Pseudomonas aeruginosa (Gram-
negative) ATCC 9027 strain; Escherichia coli (Gram-negative)K-12 strain. We also used clinical strain of 
methycillin-resistant Staphylococcus aureus (MRSA) (Gram-positive).Antimicrobial activity was determined with 
the standard serial microdilution method [3]. This method is widely used to determine growth kinetics of 
microorganisms in the presence of nanoparticles. Water dispersion of nanoparticles was prepared for this method. 
150 μl of Muller-Hinton Broth, 30 μl of bacterial suspension with 106 CFU/ml concentration and 20 μl of 
nanoparticles’ suspensions were added to 96-well microplate. Microorganisms' growth assessment was performed 
after 3, 6, 9, 12, 15, 18, 24 hours of incubation at 37°C with plate spectrophotometer Thermo Scientific Multiskan 
FC (Thermo Fisher Scientific, USA). There were not less than five measurements in parallel for each concentration 
of nanoparticles. Wells with bacterial suspension and broth were used as a control. The absorbance of the samples 
was determined before and after incubation to eliminate nanoparticles' interference.
The mouse neuroblastoma cell line Neuro-2a and mouse histiocytic sarcoma cell line J774were purchased from 
Vector, Koltsovo (Russian Federation). The cells were grown in Minimum Essential Eagle’s Medium supplemented 
with 10% fetal bovine serum and 5% penicillin streptomycin glutamine. The cells were cultured at 37°C in a 5% 
CO2 humidified atmosphere until grown to the desired density in 75 cm
2 flasks. All the materials were sterilized in 
an autoclave at 121°C for 20 min. 0.01 mg·ml–1of AlOOH/Cu nanostructures were incubated with the cells in 
24-well plates at a density of 160 000 cells per well at 37°C in a 5% CO2 humidified atmosphere for specified time 
periods of 24 h. An aliquot of suspended single cells was incubated for 5 min at room temperature with trypan blue 
vital stain in an appropriate dilution and the total viable single cells count was estimated using a hemocytometer. 
Nanoparticles were not added to the control samples.
RESULTS AND DISCUSSION
The powders were provided by the Advanced Powder Technologies Company, Tomsk, Russia 
(http://www.nanosized-powders.com/en/).Electrical explosion of wire (EEW) was used to obtain nanoparticles. Fe 
nanoparticles are formed after EEW in an argon atmosphere, electrical explosion of wire was performed in an 
oxygen atmosphere to produce Fe3O4 nanoparticles. Cu/Fe nanoparticles were produced in combined electrical 
explosion of iron and copper wire sin an argon atmosphere. Nanoparticles’ composition was adjusted by diameter of 
wires. To produce nanoparticles with mass ration 50:50 copper and iron wires with diameter 0.2 mm were used.
TABLE. Sample characteristics
Nanoparticle The average particle size, nm Specific surface area, m2/g Phase composition
Fe 87 nm 3.6 Fe
Fe3O4 77 nm 5.4 Fe2O3, FeO
Cu/Fe 63 nm 7.8 Fe, Cu
020004-2
(a) (b) (c)
FIGURE 1. TEM-image of nanoparticles: (a) Fe, (b) Fe3O4, (c) Fe/Cu
The results from characterization of nanoparticles were summarized in the Table. After EEW spherical particles 
were formed (Fig. 1). This shape was conducted by mechanism of nanoparticles formation [9]. All these 
nanoparticles were formed in liquid phase. The surface of nanoparticles was coated with a thin oxide film formed 
after passivation of the nanoparticles in air.
Mean Fe particles’ size is 87 nm, Fe3O4—77 nm, Cu/Fe—63 nm. The phase composition of all nanoparticles is 
presented in the Table. After the detailed investigation of Cu/Fe nanoparticles with EDAX-TEM analysis it can be 
noted that the particles have a complex composition (Fig. 2). All particles contain copper and iron. There are sites 
enriched with one of the components with definite phase composition.
The mechanism of antibacterial activity of Fe and Fe3O4 nanoparticles Fe and Fe3O4, has been already detailed 
by many authors, for example in [1, 9]. There are no data for Cu/Fe nanoparticles. The antimicrobial activity of 
nanoparticles has been determined in aerobic conditions by serial micro dilutions method in microplate. The water 
suspensions of Fe nanoparticles had no inhibiting effect on the growth of P. aeruginosa even in the highest 
concentration (500 μg/ml), as well as Fe3O4 nanoparticles. For gram-positive bacteria growth of S. aureus has 
stopped at 150 μg/ml concentration of Fe nanoparticles, and 100 μg/ml for Fe3O4 nanoparticles. For MRSA 250 and 
150 μg/ml respectively. In case of Cu/Fe nanoparticles a significant growth inhbition of all investigated 
microorganisms was observed. Cu/Fe nanoparticles inhibited the growth of all investigated microorganisms in the 
concentration not more than 125 μg/ml. Thus, Cu/Fe nanoparticles had the highest antimicrobial activity. Such 
particles can be perspective antimicrobial agents for new bacteriological protection technologies.
The preliminary results of nanoparticles’ anticancer activity have shown that viability of Neuro-2a cells treated 
with all nanoparticles for 24 hours decreases to 39.5% for Fe nanoparticles, lowers to 29.7% for Cu/Fe 
nanoparticles, and to 25.7% for Fe3O4 nanoparticles (Fig. 3a).
The nanoparticles also have demonstrated anticancer activity to J774 cell line (Fig. 3b). The cells viability was 
61.9% for Fe nanoparticles, 23.3% for Cu/Fe nanoparticles, and 60.9% for Fe3O4 nanoparticles. Thus, all 
nanoparticles inhibited the growth of cancer cells.
FIGURE 2. EDAX-TEM analysis of Fe/Cu nanoparticle
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FIGURE 3. Cytotoxic assays
CONCLUSION
Magnetic nanoparticles synthesized by the EEW method have antimicrobial and anticancer activity. Such 
particles can be successfully used for a wide range of therapeutic applications.
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